Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
German generics maker Stada is back to business after being acquired by CapVest Partners last year, loading itself up with 16 of Orifarm’s vitamins, minerals and supplements (VMS) brands in its fir | The deal allows Stada to bolster its consumer health presence in European pharmacies while Orifarm sharpens its focus on pharmaceuticals.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

As China-developed assets gain more attention from biopharma dealmakers, some industry watchers want to cur | As China-developed…

Antibody-drug conjugates from Kelun-Biotech and Hansoh Pharma, respectively partnered with Merck & Co. and GSK, delivered…

Amid restructuring efforts, Bayer has addressed its need for a capital infusion in pharma under a deal

Astellas CEO explained to Fierce the company's new five-year plan. A Takeda candidate beat Bristol Myers Squibb's Sotyktu in a…

With Bayer’s pharma sales growth lagging behind its crop science and consumer health divisions in the second quarter, analysts…

Takeda's first-in-class orexin treatment won an FDA nod in narcolepsy. Daiichi Sankyo faced investor pushback after admitting to…